These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The activity of constitutive nitric oxide synthase is increased by the pathway cAMP/cAMP-activated protein kinase in human platelets. New insights into the antiaggregating effects of cAMP-elevating agents. Russo I, Doronzo G, Mattiello L, De Salve A, Trovati M, Anfossi G. Thromb Res; 2004; 114(4):265-73. PubMed ID: 15381390 [Abstract] [Full Text] [Related]
3. Estrogen ameliorates trauma-hemorrhage-induced lung injury via endothelial nitric oxide synthase-dependent activation of protein kinase G. Kan WH, Hsu JT, Schwacha MG, Choudhry MA, Bland KI, Chaudry IH. Ann Surg; 2008 Aug; 248(2):294-302. PubMed ID: 18650641 [Abstract] [Full Text] [Related]
4. Dipyridamole synergizes with nitric oxide to prolong inhibition of thrombin-induced platelet shape change. Jensen BO, Kleppe R, Kopperud R, Nygaard G, Døskeland SO, Holmsen H, Selheim F. Platelets; 2011 Aug; 22(1):8-19. PubMed ID: 20958117 [Abstract] [Full Text] [Related]
5. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations. Lee HS, Kim SD, Lee WM, Endale M, Kamruzzaman SM, Oh WJ, Cho JY, Kim SK, Cho HJ, Park HJ, Rhee MH. Eur J Pharmacol; 2010 Feb 10; 627(1-3):85-91. PubMed ID: 19913011 [Abstract] [Full Text] [Related]
6. Modulation of lamellipodial structure and dynamics by NO-dependent phosphorylation of VASP Ser239. Lindsay SL, Ramsey S, Aitchison M, Renné T, Evans TJ. J Cell Sci; 2007 Sep 01; 120(Pt 17):3011-21. PubMed ID: 17684063 [Abstract] [Full Text] [Related]
8. Peroxynitrite causes phosphorylation of vasodilator-stimulated phosphoprotein through a PKC dependent mechanism. Aburima A, Riba R, Naseem KM. Platelets; 2010 Sep 01; 21(6):421-8. PubMed ID: 20624010 [Abstract] [Full Text] [Related]
9. Regulation of VASP serine 157 phosphorylation in human neutrophils after stimulation by a chemoattractant. Eckert RE, Jones SL. J Leukoc Biol; 2007 Nov 01; 82(5):1311-21. PubMed ID: 17684042 [Abstract] [Full Text] [Related]
10. Association of VASP with TRPC4 in PKG-mediated inhibition of the store-operated calcium response in mesangial cells. Wang X, Pluznick JL, Settles DC, Sansom SC. Am J Physiol Renal Physiol; 2007 Dec 01; 293(6):F1768-76. PubMed ID: 17913834 [Abstract] [Full Text] [Related]
11. Platelet resistance to the antiaggregatory cyclic nucleotides in central obesity involves reduced phosphorylation of vasodilator-stimulated phosphoprotein. Russo I, Del Mese P, Doronzo G, De Salve A, Secchi M, Trovati M, Anfossi G. Clin Chem; 2007 Jun 01; 53(6):1053-60. PubMed ID: 17463178 [Abstract] [Full Text] [Related]
15. Potent antiplatelet activity of sesamol in an in vitro and in vivo model: pivotal roles of cyclic AMP and p38 mitogen-activated protein kinase. Chang CC, Lu WJ, Chiang CW, Jayakumar T, Ong ET, Hsiao G, Fong TH, Chou DS, Sheu JR. J Nutr Biochem; 2010 Dec 01; 21(12):1214-21. PubMed ID: 20015631 [Abstract] [Full Text] [Related]
18. Human cyclic GMP-dependent protein kinase I beta overexpression increases phosphorylation of an endogenous focal contact-associated vasodilator-stimulated phosphoprotein without altering the thrombin-evoked calcium response. Meinecke M, Geiger J, Butt E, Sandberg M, Jahnsen T, Chakraborty T, Walter U, Jarchau T, Lohmann SM. Mol Pharmacol; 1994 Aug 01; 46(2):283-90. PubMed ID: 8078490 [Abstract] [Full Text] [Related]
20. Inducible nitric oxide synthase-dependent stimulation of PKGI and phosphorylation of VASP in human embryonic kidney cells. André M, Latado H, Felley-Bosco E. Biochem Pharmacol; 2005 Feb 15; 69(4):595-602. PubMed ID: 15670578 [Abstract] [Full Text] [Related] Page: [Next] [New Search]